retatrutide nejm What GLP‑3 Really Is: Triple‑Receptor Drug retatrutide phase 2 trial obesity

10.1161/STROKEAHA.119.027531 266

Some patients may benefit from referral to a British Dietetic Association (BDA) registered dietitian for personalised nutritional guidance, particularly if struggling with protein intake or experiencing significant muscle loss

Every year, the World Anti-Doping Agency (WADA) publishes an updated Prohibited List

The multidistrict litigation (MDL) was created after dozens of people filed lawsuits after they allegedly developed severe gastrointestinal complications from taking Mounjaro or another GLP-1 product

The before and after results people share online typically reflect months of use at therapeutic doses, not the starting dose period